NO981388L - Bedring av Dupuytrens sykdom - Google Patents

Bedring av Dupuytrens sykdom

Info

Publication number
NO981388L
NO981388L NO981388A NO981388A NO981388L NO 981388 L NO981388 L NO 981388L NO 981388 A NO981388 A NO 981388A NO 981388 A NO981388 A NO 981388A NO 981388 L NO981388 L NO 981388L
Authority
NO
Norway
Prior art keywords
dupuytren
disease
improvement
Prior art date
Application number
NO981388A
Other languages
English (en)
Norwegian (no)
Other versions
NO981388D0 (no
Inventor
Thomas L Wegman
Original Assignee
Advance Biofactures Curacao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance Biofactures Curacao filed Critical Advance Biofactures Curacao
Publication of NO981388D0 publication Critical patent/NO981388D0/no
Publication of NO981388L publication Critical patent/NO981388L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
NO981388A 1997-03-27 1998-03-26 Bedring av Dupuytrens sykdom NO981388L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/826,015 US6086872A (en) 1997-03-27 1997-03-27 Amelioration of dupuytren's disease

Publications (2)

Publication Number Publication Date
NO981388D0 NO981388D0 (no) 1998-03-26
NO981388L true NO981388L (no) 1998-09-28

Family

ID=25245473

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981388A NO981388L (no) 1997-03-27 1998-03-26 Bedring av Dupuytrens sykdom

Country Status (8)

Country Link
US (2) US6086872A (enExample)
AU (1) AU733208B2 (enExample)
DE (1) DE19813748A1 (enExample)
DK (1) DK177324B1 (enExample)
FR (2) FR2772273B1 (enExample)
GB (1) GB2323530B (enExample)
NO (1) NO981388L (enExample)
SE (1) SE522723C2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958150B2 (en) 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
US6022539A (en) * 1999-06-03 2000-02-08 Advance Biofactures Of Curacao Amelioration of peyronie's disease
GB0306165D0 (en) * 2003-03-18 2003-04-23 Delta G Ltd Medical treatment
PL1846022T3 (pl) * 2005-01-21 2016-06-30 Univ New York State Res Found Sposoby leczenia zarostowego zapalenia torebki stawowej
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
ITPD20050207A1 (it) 2005-07-07 2007-01-08 Fidia Farmaceutici Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
WO2008100833A2 (en) * 2007-02-13 2008-08-21 Auxilium International Holdings, Inc. Production of recombinant collagenases colg and colh in escherichia coli
US10071143B1 (en) 2007-05-03 2018-09-11 The Research Foundation For The State University Of New York Methods for non-surgical treatment of carpal tunnel syndrome
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
JP5649589B2 (ja) * 2009-03-06 2015-01-07 ハロザイム インコーポレイテッド マトリックスメタロプロテアーゼ１の温度感受性突然変異体およびその使用
WO2010111525A2 (en) 2009-03-25 2010-09-30 Agee, John, M., Trustee Of The John M. Agee Trust Of August 15, 1996 Treatment of carpal tunnel syndrome by injection of the flexor retinaculum
EP2632446B1 (en) * 2010-10-30 2018-12-12 Oxford University Innovation Limited Treatment for dupuytren's disease
WO2012125948A1 (en) 2011-03-16 2012-09-20 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
KR101921363B1 (ko) 2011-07-20 2018-11-22 메디운드 리미티드 결합 조직 질환을 치료하기 위한 브로멜라인으로부터의 단백분해 추출물
GB201119089D0 (en) 2011-11-04 2011-12-21 Isis Innovation Treatment of musculoskeletal fibroproliferative disorders
EP4276180A3 (en) 2012-01-12 2024-01-10 Endo Global Ventures Clostridium histolyticum enzyme
US20150079069A1 (en) * 2012-04-30 2015-03-19 Elastomics Ab Methods for modification of tissues
WO2014066622A2 (en) 2012-10-24 2014-05-01 The Research Foundation For The State University Of New York Use of collagenase to treat glaucoma
US20150196625A9 (en) 2013-01-07 2015-07-16 Rudolph D. Paladini Metal Sensitive Mutants of Matrix Metalloproteases and uses thereof
AU2014228477B2 (en) 2013-03-15 2019-05-23 Biospecifics Technologies Corporation Treatment method and product for uterine fibroids using purified collagenase
CN103751102A (zh) 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
KR20250021648A (ko) 2017-03-01 2025-02-13 엔도 오퍼레이션즈 리미티드 셀룰라이트를 평가하고 치료하기 위한 장치 및 방법
WO2018183582A2 (en) 2017-03-28 2018-10-04 Endo Ventures Limited Improved method of producing collagenase
US11872267B2 (en) 2019-10-15 2024-01-16 The Johns Hopkins University Treatment of uterine fibroids using purified collagenase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338300A (en) * 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
US5173295A (en) * 1990-10-05 1992-12-22 Advance Biofactures Of Curacao, N.V. Method of enhancing the regeneration of injured nerves and adhesive pharamaceutical formulation therefor
US5393792A (en) * 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
US5589171A (en) 1994-08-22 1996-12-31 Advance Biofactures Of Curacao Treatment of Dupuytren's disease with collagenase

Also Published As

Publication number Publication date
SE522723C2 (sv) 2004-03-02
DK40398A (da) 1998-09-28
FR11C0033I2 (fr) 2012-03-16
DK177324B1 (da) 2013-01-07
AU733208B2 (en) 2001-05-10
DE19813748A1 (de) 1998-10-01
FR2772273A1 (fr) 1999-06-18
USRE39941E1 (en) 2007-12-18
GB2323530B (en) 2001-10-10
GB2323530A (en) 1998-09-30
SE9800806D0 (sv) 1998-03-12
AU5966198A (en) 1998-10-01
GB9805050D0 (en) 1998-05-06
US6086872A (en) 2000-07-11
NO981388D0 (no) 1998-03-26
SE9800806L (sv) 1998-09-28
FR2772273B1 (fr) 2003-04-25
FR11C0033I1 (enExample) 2011-09-23

Similar Documents

Publication Publication Date Title
NO981388D0 (no) Bedring av Dupuytrens sykdom
CY2018020I1 (el) Θεραπεια της νοσου ρομρε
NO953262D0 (no) Bedring av Dupuytrens sykdom
NO20002686L (no) Forbedring av Peyronies sykdom
NO982473D0 (no) 5'-Deoksy-cytidinderivater
NO20001869D0 (no) Fremgangsmõte for behandling av Alzheimerssykdom
TR199701051A3 (tr) 2' -Fluoro-5-metil- -l-arabino-furanosilüridin hazirlanma prosesi
IT244003Y1 (it) Tenuta d'albero
UA1629S (uk) Набір фестонів "веснянка-5"
UA25492A (uk) Спосіб лікуваhhя хвороби гіршпруhга
UA1951S (uk) Етикетка медичного препарату "валідол"
UA1957S (uk) Етикетка медичного препарату "аспаркам"
UA2094S (uk) Етикетка медичного препарату "аспаркам"
GB9717142D0 (en) Diagnosis of alzheimer's disease
KR960031066U (ko) 자동차용 인사이드 밀러의 체결구조
UA1150S (uk) Гра кубики-абетка "піктограми-здоров'я"
UA1999S (uk) Етикетка медичного препарату "димексид"
UA2230S (uk) Етикетка медичного препарату "гідроперит"
MA26665A1 (fr) Combination d'anticorps
UA1484S (uk) Міні-пальто жіноче хутрове
UA1579S (uk) Міні-пальто жіноче хутрове
UA1581S (uk) Міні-пальто жіноче хутрове
UA1582S (uk) Міні-пальто жіноче хутрове
UA1529S (uk) Міні-пальто жіноче хутрове
UA1488S (uk) Міні-пальто жіноче хутрове

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application